Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 773

1.

Mouse HSA+ immature cardiomyocytes persist in the adult heart and expand after ischemic injury.

Valente M, Resende TP, Nascimento DS, Burlen-Defranoux O, Soares-da-Silva F, Dupont B, Cumano A, Pinto-do-Ó P.

PLoS Biol. 2019 Jun 27;17(6):e3000335. doi: 10.1371/journal.pbio.3000335. eCollection 2019 Jun.

2.

Has adherence to treatment guidelines for mid/low rectal cancer affected the management of patients? A monocentric study of 604 consecutive patients.

Eid Y, Menahem B, Bouvier V, Lebreton G, Thobie A, Bazille C, Finochi M, Fohlen A, Galais MP, Dupont B, Lubrano J, Dejardin O, Morello R, Alves A.

J Visc Surg. 2019 Mar 12. pii: S1878-7886(19)30001-3. doi: 10.1016/j.jviscsurg.2019.01.001. [Epub ahead of print]

PMID:
30876923
3.

Transhepatic forceps biopsy combined with biliary drainage in obstructive jaundice: safety and accuracy.

Fohlen A, Bazille C, Menahem B, Jegonday MA, Dupont B, Le Pennec V, Lubrano J, Guiu B, Pelage JP.

Eur Radiol. 2019 May;29(5):2426-2435. doi: 10.1007/s00330-018-5852-x. Epub 2018 Dec 3.

PMID:
30511177
4.

Exploring the Factors Associated With Rejection From a Closed Cybercrime Community.

Holt TJ, Dupont B.

Int J Offender Ther Comp Criminol. 2019 Jun;63(8):1127-1147. doi: 10.1177/0306624X18811101. Epub 2018 Nov 7.

PMID:
30403151
5.

Variability in Phelan-McDermid syndrome: The impact of the PNPLA3 p.I148M polymorphism.

Boccuto L, Abenavoli L, Cascio L, Srikanth S, DuPont B, Mitz AR, Rogers RC, Phelan K.

Clin Genet. 2018 Dec;94(6):590-591. doi: 10.1111/cge.13451. Epub 2018 Oct 11.

PMID:
30308089
6.

Anterior resection syndrome: What should we tell practitioners and patients in 2018?

Sarcher T, Dupont B, Alves A, Menahem B.

J Visc Surg. 2018 Oct;155(5):383-391. doi: 10.1016/j.jviscsurg.2018.03.006. Epub 2018 Aug 17.

PMID:
30126800
7.

Non-invasive, transdermal, path-selective and specific glucose monitoring via a graphene-based platform.

Lipani L, Dupont BGR, Doungmene F, Marken F, Tyrrell RM, Guy RH, Ilie A.

Nat Nanotechnol. 2018 Jun;13(6):504-511. doi: 10.1038/s41565-018-0112-4. Epub 2018 Apr 9.

PMID:
29632401
8.

Is pathological complete response after a trimodality therapy, a predictive factor of long-term survival in locally-advanced esophageal cancer? Results of a retrospective monocentric study.

Francoual J, Lebreton G, Bazille C, Galais MP, Dupont B, Alves A, Lubrano J, Morello R, Menahem B.

J Visc Surg. 2018 Oct;155(5):365-374. doi: 10.1016/j.jviscsurg.2018.02.003. Epub 2018 Feb 28.

PMID:
29501383
9.

Balanced Ambipolar Organic Field-Effect Transistors by Polymer Preaggregation.

Janasz L, Luczak A, Marszalek T, Dupont BGR, Jung J, Ulanski J, Pisula W.

ACS Appl Mater Interfaces. 2017 Jun 21;9(24):20696-20703. doi: 10.1021/acsami.7b03399. Epub 2017 Jun 12.

PMID:
28560870
10.

Preoperative Biliary Drainage in Patients with Resectable Perihilar Cholangiocarcinoma: Is Percutaneous Transhepatic Biliary Drainage Safer and More Effective than Endoscopic Biliary Drainage? A Meta-Analysis.

Al Mahjoub A, Menahem B, Fohlen A, Dupont B, Alves A, Launoy G, Lubrano J.

J Vasc Interv Radiol. 2017 Apr;28(4):576-582. doi: 10.1016/j.jvir.2016.12.1218. Review.

PMID:
28343588
11.

An estimation of burden of serious fungal infections in France.

Gangneux JP, Bougnoux ME, Hennequin C, Godet C, Chandenier J, Denning DW, Dupont B; LIFE program, the Société française de mycologie médicale SFMM-study group.

J Mycol Med. 2016 Dec;26(4):385-390. doi: 10.1016/j.mycmed.2016.11.001. Epub 2016 Nov 22. Review.

PMID:
27887809
12.

Utility of serum anti-cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab.

Dupont B, Mariotte D, Dugué AE, Clarisse B, Grellard JM, Babin E, Chauffert B, Dakpé S, Moldovan C, Bouhier-Leporrier K, Reimund JM, Di Fiore F, Zanetta S, Mailliez A, Do P, Peytier A, Galais MP, Florescu C, Schott R, Le Mauff B, Gervais R.

Br J Clin Pharmacol. 2017 Mar;83(3):623-631. doi: 10.1111/bcp.13140. Epub 2016 Oct 24.

13.

Importance of genetic testing in global health during the evaluation of familial microcephaly.

Molinero I, Broman-Fulks J, Lyons MJ, Matheus MG, Chaubey A, DuPont BR, Friez MJ, Skinner SA, Holden KR.

Clin Case Rep. 2016 Aug 26;4(10):968-971. eCollection 2016 Oct.

14.

Proposal of a novel MELD exception point system for hepatocellular carcinoma based on tumor characteristics and dynamics.

Bhat M, Ghali P, Dupont B, Hilzenrat R, Tazari M, Roy A, Chaudhury P, Alvarez F, Carrier M, Bilodeau M.

J Hepatol. 2017 Feb;66(2):374-381. doi: 10.1016/j.jhep.2016.10.008. Epub 2016 Oct 15.

PMID:
27751840
15.

Concomitant 11p15.4-p15.5 duplication and terminal 22q13.33 deletion in a patient with features of Beckwith-Wiedemann syndrome.

Peterson JF, Bick DP, Geddes GC, McCarrier J, Grignon JW Jr, Chirempes B, Broeckel U, Abidi F, Rogers RC, Boccuto L, DuPont B, vanTuinen P.

Am J Med Genet A. 2016 Dec;170(12):3348-3351. doi: 10.1002/ajmg.a.37939. Epub 2016 Aug 23. No abstract available.

PMID:
27549580
16.

Cell-Extrinsic MHC Class I Molecule Engagement Augments Human NK Cell Education Programmed by Cell-Intrinsic MHC Class I.

Boudreau JE, Liu XR, Zhao Z, Zhang A, Shultz LD, Greiner DL, Dupont B, Hsu KC.

Immunity. 2016 Aug 16;45(2):280-91. doi: 10.1016/j.immuni.2016.07.005. Epub 2016 Aug 2.

17.

Highlights of the Fourth Canadian Symposium on Hepatitis C: Moving towards a National Action Plan.

Sagan SM, Dupont B, Grebely J, Krajden M, MacParland SA, Raven JF, Saeed S, Feld JJ, Tyrrell DL, Wilson JA.

Can J Gastroenterol Hepatol. 2016;2016:5743521. doi: 10.1155/2016/5743521. Epub 2016 Apr 27.

18.

A non-steroidal anti-inflammatory drug to treat eumycetoma.

Dupont B.

Lancet Infect Dis. 2016 Jul;16(7):779. doi: 10.1016/S1473-3099(16)30152-9. No abstract available.

PMID:
27352758
19.

Role of a NSAID in the apparent cure of a fungal mycetoma.

Dupont B, Datry A, Poirée S, Canestri A, Boucheneb S, Fourniols E.

J Mycol Med. 2016 Jun;26(2):86-93. doi: 10.1016/j.mycmed.2016.03.003. Epub 2016 May 24.

PMID:
27233662
20.

Soluble and membrane-bound interleukin (IL)-15 Rα/IL-15 complexes mediate proliferation of high-avidity central memory CD8+ T cells for adoptive immunotherapy of cancer and infections.

Hasan AN, Selvakumar A, Shabrova E, Liu XR, Afridi F, Heller G, Riviere I, Sadelain M, Dupont B, O'Reilly RJ.

Clin Exp Immunol. 2016 Nov;186(2):249-265. doi: 10.1111/cei.12816. Epub 2016 Aug 31.

21.

Complex Chromosomal Rearrangements in B-Cell Lymphoma: Evidence of Chromoanagenesis? A Case Report.

Ortega V, Chaubey A, Mendiola C, Ehman W Jr, Vadlamudi K, Dupont B, Velagaleti G.

Neoplasia. 2016 Apr;18(4):223-8. doi: 10.1016/j.neo.2016.02.004.

22.

Timing and Route of Enteral Nutrition in Severe Acute Pancreatitis?

Dupont B, Musikas M, Dao MT, Piquet MA.

Pancreas. 2016 May-Jun;45(5):e20. doi: 10.1097/MPA.0000000000000560. No abstract available.

PMID:
27077719
23.

Association of a variable number tandem repeat in the NLRP3 gene in women with susceptibility to RVVC.

Jaeger M, Carvalho A, Cunha C, Plantinga TS, van de Veerdonk F, Puccetti M, Galosi C, Joosten LA, Dupont B, Kullberg BJ, Sobel JD, Romani L, Netea MG.

Eur J Clin Microbiol Infect Dis. 2016 May;35(5):797-801. doi: 10.1007/s10096-016-2600-5. Epub 2016 Mar 7.

24.
25.

Re. "Early oral refeeding based on hunger in moderate and severe acute pancreatitis: A prospective controlled, randomized clinical trial": Can we really do without enteral nutrition?

Dupont B, Piquet MA.

Nutrition. 2016 Jan;32(1):154. doi: 10.1016/j.nut.2015.04.012. Epub 2015 May 14. No abstract available.

PMID:
26643751
26.

Microdeletions on 6p22.3 are associated with mesomelic dysplasia Savarirayan type.

Flöttmann R, Wagner J, Kobus K, Curry CJ, Savarirayan R, Nishimura G, Yasui N, Spranger J, Van Esch H, Lyons MJ, DuPont BR, Dwivedi A, Klopocki E, Horn D, Mundlos S, Spielmann M.

J Med Genet. 2015 Jul;52(7):476-83. doi: 10.1136/jmedgenet-2015-103108. Epub 2015 Jun 1.

PMID:
26032025
27.

Retrospective evaluation of prognostic score performances in cirrhotic patients admitted to an intermediate care unit.

Dupont B, Delvincourt M, Koné M, du Cheyron D, Ollivier-Hourmand I, Piquet MA, Terzi N, Dao T.

Dig Liver Dis. 2015 Aug;47(8):675-81. doi: 10.1016/j.dld.2015.04.001. Epub 2015 Apr 13.

PMID:
25937626
28.

Clinical performance of the CytoScan Dx Assay in diagnosing developmental delay/intellectual disability.

Pfundt R, Kwiatkowski K, Roter A, Shukla A, Thorland E, Hockett R, DuPont B, Fung ET, Chaubey A.

Genet Med. 2016 Feb;18(2):168-73. doi: 10.1038/gim.2015.51. Epub 2015 Apr 16.

PMID:
25880438
29.

[The French society of medical mycology in 2015].

Gangneux JP, Dupont B.

J Mycol Med. 2015 Mar;25(1):1. doi: 10.1016/j.mycmed.2015.02.045. French. No abstract available.

PMID:
25766569
30.

Utility and impact of early t(15;17) identification by Fluorescence In Situ Hybridization (FISH) in clinical decision making for patients in Acute Promyelocytic Leukemia (APL).

Kolhe R, Mangaonkar A, Mansour J, Clemmons A, Shaw J, Dupont B, Walczak L, Mondal A, Rojiani A, Jillella A, Kota V.

Int J Lab Hematol. 2015 Aug;37(4):515-20. doi: 10.1111/ijlh.12326. Epub 2015 Jan 14.

PMID:
25639817
31.

Clinical utility of chromosomal microarray analysis in the diagnosis and management of monosomy 7 mosaicism.

Dwivedi AC, Lyons MJ, Kwiatkowski K, Bartel FO, Friez MJ, Holden KR, Fung ET, DuPont BR.

Mol Cytogenet. 2014 Dec 4;7(1):93. doi: 10.1186/s13039-014-0093-4. eCollection 2014.

32.

Risk factors associated with hypersensitivity reactions to cetuximab: anti-cetuximab IgE detection as screening test.

Dupont B, Mariotte D, Clarisse B, Galais MP, Bouhier-Leporrier K, Grellard JM, Le Mauff B, Reimund JM, Gervais R.

Future Oncol. 2014 Nov;10(14):2133-40. doi: 10.2217/fon.14.153.

PMID:
25471028
33.

Donor activating KIR2DS1 in leukemia.

Venstrom JM, Dupont B, Hsu KC, Pittari G, Gooley TA, Chewning JH, Spellman S, Haagenson M, Gallagher MM, Malkki M, Petersdorf E.

N Engl J Med. 2014 Nov 20;371(21):2042. doi: 10.1056/NEJMc1411443. No abstract available.

PMID:
25409391
34.

Deletion of 16q24.1 supports a role for the ATP2C2 gene in specific language impairment.

Smith AW, Holden KR, Dwivedi A, Dupont BR, Lyons MJ.

J Child Neurol. 2015 Mar;30(4):517-21. doi: 10.1177/0883073814545113. Epub 2014 Oct 7.

PMID:
25296922
35.

Gene polymorphisms in pattern recognition receptors and susceptibility to idiopathic recurrent vulvovaginal candidiasis.

Rosentul DC, Delsing CE, Jaeger M, Plantinga TS, Oosting M, Costantini I, Venselaar H, Joosten LA, van der Meer JW, Dupont B, Kullberg BJ, Sobel JD, Netea MG.

Front Microbiol. 2014 Sep 23;5:483. doi: 10.3389/fmicb.2014.00483. eCollection 2014.

36.

19q13.32 microdeletion syndrome: three new cases.

Castillo A, Kramer N, Schwartz CE, Miles JH, DuPont BR, Rosenfeld JA, Graham JM Jr.

Eur J Med Genet. 2014 Nov-Dec;57(11-12):654-8. doi: 10.1016/j.ejmg.2014.08.009. Epub 2014 Sep 16.

PMID:
25230004
37.

Late occurrence of Histoplasma duboisii cutaneous and pulmonary infection 18 years after exposure.

Régnier-Rosencher E, Dupont B, Jacobelli S, Paugam A, Carlotti A, Boitier F, Gorin I, Dupin N, Avril MF.

J Mycol Med. 2014 Sep;24(3):229-33. doi: 10.1016/j.mycmed.2014.08.001. Epub 2014 Aug 23.

PMID:
25155354
38.

Neurodevelopmental delays and macrocephaly in 17p13.1 microduplication syndrome.

Mooneyham KA, Holden KR, Cathey S, Dwivedi A, Dupont BR, Lyons MJ.

Am J Med Genet A. 2014 Nov;164A(11):2887-91. doi: 10.1002/ajmg.a.36708. Epub 2014 Aug 13.

PMID:
25123844
39.

Case Report About Fatal or Near-Fatal Hypersensitivity Reactions to Cetuximab: Anticetuximab IgE as a Valuable Screening Test.

Dupont B, Mariotte D, Moldovan C, Grellard JM, Vergnaud MC, Laroche D, Gervais R.

Clin Med Insights Oncol. 2014 Jul 6;8:91-4. doi: 10.4137/CMO.S13897. eCollection 2014.

40.

Acquired microcephaly in blepharophimosis-ptosis-epicanthus inversus syndrome because of an interstitial 3q22.3q23 deletion.

Dean SJ, Holden KR, Dwivedi A, Dupont BR, Lyons MJ.

Pediatr Neurol. 2014 Jun;50(6):636-9. doi: 10.1016/j.pediatrneurol.2014.01.055. Epub 2014 Feb 10.

PMID:
24725350
41.

Clinical and genomic evaluation of 201 patients with Phelan-McDermid syndrome.

Sarasua SM, Boccuto L, Sharp JL, Dwivedi A, Chen CF, Rollins JD, Rogers RC, Phelan K, DuPont BR.

Hum Genet. 2014 Jul;133(7):847-59. doi: 10.1007/s00439-014-1423-7. Epub 2014 Jan 31.

PMID:
24481935
42.

22q13.2q13.32 genomic regions associated with severity of speech delay, developmental delay, and physical features in Phelan-McDermid syndrome.

Sarasua SM, Dwivedi A, Boccuto L, Chen CF, Sharp JL, Rollins JD, Collins JS, Rogers RC, Phelan K, DuPont BR.

Genet Med. 2014 Apr;16(4):318-28. doi: 10.1038/gim.2013.144. Epub 2013 Oct 17.

PMID:
24136618
43.

Variant ATRX syndrome with dysfunction of ATRX and MAGT1 genes.

Qiao Y, Mondal K, Trapani V, Wen J, Carpenter G, Wildin R, Price EM, Gibbons RJ, Eichmeyer J, Jiang R, DuPont B, Martell S, Lewis SM, Robinson WP, O'Driscoll M, Wolf FI, Zwick ME, Rajcan-Separovic E.

Hum Mutat. 2014 Jan;35(1):58-62.

PMID:
24130152
44.

Disruption of MBD5 contributes to a spectrum of psychopathology and neurodevelopmental abnormalities.

Hodge JC, Mitchell E, Pillalamarri V, Toler TL, Bartel F, Kearney HM, Zou YS, Tan WH, Hanscom C, Kirmani S, Hanson RR, Skinner SA, Rogers RC, Everman DB, Boyd E, Tapp C, Mullegama SV, Keelean-Fuller D, Powell CM, Elsea SH, Morton CC, Gusella JF, DuPont B, Chaubey A, Lin AE, Talkowski ME.

Mol Psychiatry. 2014 Mar;19(3):368-79. doi: 10.1038/mp.2013.42. Epub 2013 Apr 16.

45.

NK cell tolerance of self-specific activating receptor KIR2DS1 in individuals with cognate HLA-C2 ligand.

Pittari G, Liu XR, Selvakumar A, Zhao Z, Merino E, Huse M, Chewning JH, Hsu KC, Dupont B.

J Immunol. 2013 May 1;190(9):4650-60. doi: 10.4049/jimmunol.1202120. Epub 2013 Apr 3.

46.

Clinical utility of the X-chromosome array.

Zarate YA, Dwivedi A, Bartel FO, Bellomo MA, Cathey SS, Champaigne NL, Clarkson LK, Dupont BR, Everman DB, Geer JS, Gordon BC, Lichty AW, Lyons MJ, Rogers RC, Saul RA, Schroer RJ, Skinner SA, Stevenson RE.

Am J Med Genet A. 2013 Jan;161A(1):120-30. doi: 10.1002/ajmg.a.35698. Epub 2012 Dec 3.

PMID:
23208842
47.

HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.

Venstrom JM, Pittari G, Gooley TA, Chewning JH, Spellman S, Haagenson M, Gallagher MM, Malkki M, Petersdorf E, Dupont B, Hsu KC.

N Engl J Med. 2012 Aug 30;367(9):805-16. doi: 10.1056/NEJMoa1200503.

48.

Prevalence of SHANK3 variants in patients with different subtypes of autism spectrum disorders.

Boccuto L, Lauri M, Sarasua SM, Skinner CD, Buccella D, Dwivedi A, Orteschi D, Collins JS, Zollino M, Visconti P, Dupont B, Tiziano D, Schroer RJ, Neri G, Stevenson RE, Gurrieri F, Schwartz CE.

Eur J Hum Genet. 2013 Mar;21(3):310-6. doi: 10.1038/ejhg.2012.175. Epub 2012 Aug 15.

49.

Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment.

Tarek N, Le Luduec JB, Gallagher MM, Zheng J, Venstrom JM, Chamberlain E, Modak S, Heller G, Dupont B, Cheung NK, Hsu KC.

J Clin Invest. 2012 Sep;122(9):3260-70. doi: 10.1172/JCI62749. Epub 2012 Aug 6.

50.

Unbalanced translocation involving partial trisomy 9p and partial monosomy yq with neurodevelopmental delays.

Lyons MJ, Fuller JD, Montoya Mdel C, DuPont BR, Holden KR.

J Child Neurol. 2013 Apr;28(4):524-6. doi: 10.1177/0883073812446309. Epub 2012 Jun 29.

PMID:
22752474

Supplemental Content

Loading ...
Support Center